Whole Genome Sequencing (WGS)
WGS is a new comprehensive parallel sequencing method. WGS is the sequencing of an individual’s entire genome, including both protein-coding and non-protein coding (including regulatory) regions. The next step in the evolution of healthcare is the integration of WGS into all aspects of modern medicine.
WGS is becoming the preferred method for molecular genetic diagnosis of rare and unknown diseases and for identifying actionable cancer drivers. Compared to other molecular genetic methods, WGS captures most of the genomic variation and eliminates the need for sequential genetic testing. Compared to WGS, WES significantly reduces sequencing costs by focusing only on ~1-2% of the genome. Thus, for researchers focusing on protein-coding regions, WES offers a cost-effective alternative to WGS by enabling deeper sequence coverage of target regions and simplifying data analysis.
Sample type: Blood sample in EDTA containing tube
Time to obtain result: ~1-2 month